Pramipexole

Pramipexole is the generic form of Mirapexin, a dopamine agonist used for Parkinson's disease and moderate to severe restless legs syndrome. It preferentially binds to dopamine D3 receptors, which may contribute to mood-enhancing effects alongside motor symptom improvement. Generic pramipexole is bioequivalent to the branded product, offering the same efficacy at a more accessible price.

How to Take Pramipexole

For Parkinson's disease, pramipexole is taken three times daily (immediate-release tablets) or once daily (prolonged-release tablets). Always start at the lowest available dose and increase gradually every five to seven days, as your doctor advises. For restless legs syndrome (RLS), take once daily, two to three hours before bedtime.

The gradual dose titration is important, increasing too quickly causes more nausea and dizziness. Take with food if you experience stomach upset. Do not stop pramipexole suddenly, as this can cause a withdrawal syndrome with anxiety, sweating, and in Parkinson's patients, a worsening of motor symptoms.

Same dosing as Mirapexin. Parkinson's: start at 0.088 mg three times daily, titrating upward. RLS: start at 0.088 mg daily. Prolonged-release: start at 0.26 mg once daily.

Common Side Effects

Common side effects include:

• Nausea (especially at the start of treatment or after dose increases)
• Dizziness and unsteadiness
• Excessive sleepiness (somnolence) and sudden sleep attacks
• Hallucinations (particularly in elderly patients)
• Involuntary movements (dyskinesia)
• Low blood pressure on standing

Sudden sleep attacks have been reported with pramipexole and other dopamine agonists. Do not drive or operate heavy machinery until you know how this medication affects you. Some patients experience impulse control disorders, including compulsive gambling, binge eating, or hypersexuality. Tell your doctor straight away if you notice any of these behavioural changes.

May cause sudden sleep episodes. Monitor for impulse control disorders. Do not stop abruptly; taper gradually to avoid withdrawal symptoms including dopamine agonist withdrawal syndrome.

Contraindicated in known hypersensitivity to pramipexole or any excipient.